Genui and SHS Capital Invest in Germany’s ROTOP to Strengthen Radiopharmaceuticals Industry 💊

ROTOP Pharmaka GmbH, a leading German manufacturer and CDMO specializing in radiopharmaceuticals, has secured a strategic investment from Genui and SHS Capital. This partnership is set to enhance ROTOP’s expertise in developing and producing innovative medical imaging and therapeutic solutions, reinforcing its role in the growing radiopharmaceutical market. With this capital injection, ROTOP aims to expand its capabilities, drive innovation, and strengthen its market presence both in Germany and internationally. This investment highlights the increasing importance of radiopharmaceuticals in modern healthcare, particularly in diagnostics and targeted therapies. Photo: rotop-pharmaka.de

October 2026

S

M

T

W

T

F

S

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31